Japan Genetic Testing Market Size and Growth Overview (2026-2034)

Market Size in 2025: USD 651.9 Million

Market Forecast in 2034: USD 4,109.2 Million

Market Growth Rate 2026-2034: 22.70%

According to the latest report by IMARC Group, Japan genetic testing market size reached USD 651.9 million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,109.2 million by 2034, exhibiting a growth rate (CAGR) of 22.70% during 2026-2034.

Request PDF Sample for more detailed market insights: https://www.imarcgroup.com/japan-genetic-testing-market/requestsample

Japan Genetic Testing Market Trends & Drivers

Advancements in the healthcare system and its culture have resulted in an increase in the demand for genetic testing services in Japan. This demand has also been spurred on by Japan's continued focus on innovation and precision medicine and its pro-technology, pro-innovation culture. With an increasing aging population and the subsequent increase in healthcare needs, genetic testing has become a useful tool in identifying and managing a number of genetic diseases and disorders. Genetic testing is also popular with consumers for its potential to improve healthcare decisions based on genetic information. Japanese citizens are becoming increasingly aware of genetic testing's ability to provide personalized therapies, disease prevention measures, and lifestyle changes, thus contributing to greater demand for clinical and direct-to-consumer genetic testing services.

With biotechnology and R&D being key components of Japan's advanced technology utilization, the development of a wide range of advanced DNA tests, from disease susceptibility testing to pharmacogenomics, has emerged. Investments in research and development (R&D) are a major impetus for growth, enabling Japanese laboratories and biotechnology companies to develop tests that are more specific, holistic, and affordable. The rise of next-generation sequencing, molecular diagnostics, and artificial intelligence platforms has increased the utility of genetic information, while the development of the genetic testing market in Japan is eased by its developed healthcare system and increased application of genetic testing in day-to-day medical practice. The genetic testing market is expected to continue to grow and advance due to an increase in healthcare informatics and genomic research investments, advancements in the areas of technological application and clinical adoption, and consumer awareness regarding the application of personalized medicine.

Japan Genetic Testing Industry Segmentation:

The report has segmented the market into the following categories:

Breakup by Type:

• Predictive and Presymptomatic Testing
• Carrier Testing
• Prenatal and Newborn Testing
• Diagnostic Testing
• Pharmacogenomic Testing
• Others

Breakup by Technology:

• Cytogenetic Testing and Chromosome Analysis
• Biochemical Testing
• Molecular Testing (DNA Sequencing, Others)

Breakup by Application:

• Cancer Diagnosis
• Genetic Disease Diagnosis
• Cardiovascular Disease Diagnosis
• Others

Breakup by Region:

• Kanto Region
• Kansai/Kinki Region
• Central/Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region

Request a Customized Version of This Report for Deeper Insights: https://www.imarcgroup.com/request?type=report&id=16295&flag=E

Competitive Landscape:

The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant.

Future Outlook

The Japan genetic testing market is positioned for exceptional growth through 2034, driven by accelerating technological innovation, expanding clinical applications, and increasing consumer adoption of personalized medicine approaches. The market will benefit from continued advances in sequencing technologies that reduce costs while improving the accuracy and comprehensiveness of genetic analysis. Growing integration of genetic testing into preventive healthcare programs, cancer screening initiatives, and pharmacogenomic applications will expand market reach across diverse patient populations.

Key highlights of the report:

• Market Performance (2020-2025)
• Market Outlook (2026-2034)
• COVID-19 Impact on the Market
• Porter's Five Forces Analysis
• Strategic Recommendations
• Historical, Current, and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:
Street: 563-13 Kamien
Area: Iwata
Country: Tokyo, Japan
Postal Code: 4380111
Email: sales@imarcgroup.com